ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001

1978, ’79 budget Projections By Research Programs

November 25, 1977

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

Citizens Committee Notes Broad Support For NCI Funds

August 24, 1979

Fox Retirement Marks End of Era for NCI Construction Program

October 6, 1989

Screening Concepts For Minority Women and Hispanics Approved

May 26, 1989